Sergio L. Santillana - Net Worth and Insider Trading
Sergio L. Santillana Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sergio L. Santillana owns 2 companies in total, including Merrimack Pharmaceuticals Inc (MACK) , and Ikena Oncology Inc (IKNA) .
Click here to see the complete history of Sergio L. Santillana’s form 4 insider trades.
Insider Ownership Summary of Sergio L. Santillana
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2017-06-12 | Chief Medical Officer |
| IKNA | Ikena Oncology Inc | 2021-03-25 | Chief Medical Officer |
Sergio L. Santillana Trading Performance
Sergio L. Santillana Ownership Network
Sergio L. Santillana Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Sergio L. Santillana is the Chief Medical Officer of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Sergio L. Santillana made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 607,008 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 611,008 shares were bought by its insiders, resulting in a net purchase of 611,008 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Sergio L. Santillana Mailing Address
Above is the net worth, insider trading, and ownership report for Sergio L. Santillana. You might contact Sergio L. Santillana via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
